Thursday, August 27, 2020 2:16:31 PM
“I have read a lot of uninformed nonsense and had to join...“
Hahaha! Well if that isn’t rude.
I have been posting here for six years now. People can post their thoughts without being dismissed so rudely haha. At the same time I could careless about your thoughts which provided nothing new. Thank you for your input though. I have been invested in the company for a little less than seven years. Checkout my posts if you think I’m lying. Anyway, didn’t Korenko say IDE would take more than 30 days or did he circle back and correct himself like he does sometimes. I’m not bashing him for it...we are all human. We all make mistakes. I am pro Vivos. I just think that it will take more time—hold for me. The share price says to me that some shareholders feel a different way for one reason or another. I don’t fault them. In MY opinion this will take longer. If it doesn’t than it will be the best wrong to be.
Good luck to you all.
Hahaha! Well if that isn’t rude.
I have been posting here for six years now. People can post their thoughts without being dismissed so rudely haha. At the same time I could careless about your thoughts which provided nothing new. Thank you for your input though. I have been invested in the company for a little less than seven years. Checkout my posts if you think I’m lying. Anyway, didn’t Korenko say IDE would take more than 30 days or did he circle back and correct himself like he does sometimes. I’m not bashing him for it...we are all human. We all make mistakes. I am pro Vivos. I just think that it will take more time—hold for me. The share price says to me that some shareholders feel a different way for one reason or another. I don’t fault them. In MY opinion this will take longer. If it doesn’t than it will be the best wrong to be.
Good luck to you all.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
